Text Size

Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00322504
First received: May 5, 2006
Last updated: January 6, 2010
Last verified: November 2006
History of Changes
  Purpose

To assess the efficacy of acupuncture treatment in reducing symptoms of anxiety in women recently diagnosed with cancer.

• To assess the efficacy of acupuncture treatment on improving perceived quality of life in women recently diagnosed with cancer.


Condition Intervention
Breast Cancer
 Procedure: Accupuncture

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of New Mexico:

Estimated Enrollment: 10
Study Start Date: January 2006
Estimated Study Completion Date: September 2006
Detailed Description:

This is a feasibility study of acupuncture for anxiety reduction in women with breast cancer. Ten patients will be recruited at the UNM Cancer Research Treatment Center via the Breast Clinic and screened for anxiety. Treatment will consist of 10 acupuncture sessions over 5 weeks. Measures (Hopkins Symptom Checklist, Sheehan Disability Index) will be administered and analyzed for treatment effect on scores.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Woman age 18 years or older excluding the need for parental/guardian permission.
  • Histologic diagnosis of breast cancer.
  • Having a minimum anxiety score of 1.75 on the Hopkins Symptom Checklist (HSCL) with sufficient English language proficiency for the investigators to make this determination.
  • Able to give informed consent.
  • Willingness to participate in the study and receive 10 acupuncture treatments in 5 weeks.
  • Ability to fill out questionnaires and communicate with the research staff

Exclusion Criteria:

  • Males with breast cancer
  • Psychoses or a major personality disorder
  • Current use of opiates,
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00322504

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87114
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Brian Shelley University of New Mexico
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00322504     History of Changes
Other Study ID Numbers: INST 0520C
Study First Received: May 5, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 22, 2013